Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

BMJ 2002; 325 doi: http://dx.doi.org/10.1136/bmj.325.7374.1202 (Published 23 November 2002)
Cite this as: BMJ 2002;325:1202

Related articles

Research: The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis

Research: Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study

Analysis and Comment: Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence

Editorial: The polypill and cardiovascular disease

Letter: Folate and risk of cardiovascular disease

This Week In the BMJ: High homocysteine causes cardiovascular disease

See more

Research News: Impact of polypill difficult to demonstrate from varied studies, say Cochrane reviewers

Editor's Choice: The pressures of pregnancy

Practice: Drowning

Research: Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis

Editorial: Chronic hypertension during pregnancy

This article has been cited by other articles: